Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/15813
Title: Identification of metabolites of meisoindigo from interspecies microsomes and in vivo biological fluids in rats by liquid chromatography tandem mass spectrometry
Authors: HUANG MENG
Keywords: meisoindigo, LC-MS/MS, metabolite identification, metabolic stability, in vitro, in vivo
Issue Date: 16-Jun-2009
Source: HUANG MENG (2009-06-16). Identification of metabolites of meisoindigo from interspecies microsomes and in vivo biological fluids in rats by liquid chromatography tandem mass spectrometry. ScholarBank@NUS Repository.
Abstract: Meisoindigo has been a routine therapeutic agent for CML in China. However, information relevant to its metabolism is limited. In this thesis, in vitro metabolism studies were firstly carried out in rat, pig and human liver microsomes of different genders by LC-MS/MS. The in vitro metabolic pathways of meisoindigo in three species were proposed. Statistical analysis showed there were no significant differences in the metabolic stability profiles of meisoindigo among three species, and gender effect was negligible. Secondly, in vitro extrahepatic metabolism of meisoindigo in rat kidney microsomes was qualitatively and quantitatively investigated by LC-MS/MS. Thirdly, in vivo circulatory metabolites of meisoindigo in male rat plasma, excretory metabolites in male rat urine and feces were identified by LC-MS/MS. The phase I metabolic pathways showed a significant in vitro-in vivo correlation in rat. This study shed new light in the metabolic profiles of meisoindigo in rat, pig and human.
URI: http://scholarbank.nus.edu.sg/handle/10635/15813
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
HuangM.pdf1.83 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

284
checked on Jan 14, 2018

Download(s)

493
checked on Jan 14, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.